PuriCore Investment Thesis
- Critical need for safe, effective, natural solutions to control the spread of infectious pathogens.
- Scientifically proven. Intellectually protected.
- Significant share and leadership already in core markets.
- Leverageable platform technology and competencies.
- Strong revenue and margin growth in predictable model.
Latest Announcements
Information on this page is updated via a feed from the London Stock Exchange's Regulatory News Service.
- 01/10/08 - Raises $9.74 million
- 11/09/08 - Holding(s) in Company
- 04/09/08 - Holding(s) in Company
15 minute delayed prices from the London Stock Exchange provided by Hemscott Group Limited.
